Skip to main content
WAKAMOTO PHARMACEUTICAL CO.,LTD. logo

WAKAMOTO PHARMACEUTICAL CO.,LTD. — Investor Relations & Filings

Ticker · 4512 ISIN · JP3991200001 T Manufacturing
Open in API
Filings indexed 59 across all filing types
Latest filing 2022-06-24 Annual Report
Country JP Japan
Listing T 4512

About WAKAMOTO PHARMACEUTICAL CO.,LTD.

https://www.wakamoto-pharm.co.jp/englis…

WAKAMOTO PHARMACEUTICAL CO., LTD. is a company engaged in the research, development, production, and sale of pharmaceuticals. Its business encompasses both ethical (prescription) drugs and over-the-counter (OTC) products, as well as medical devices and health foods. The company specializes in therapeutic areas such as gastroenterology and is known as a pioneer in self-medication, with its flagship product being the nutrient-rich gastrointestinal remedy, "WAKAMOTO". The company actively manages a drug pipeline and engages in clinical trials to bring new therapeutic solutions to market.

Recent filings

Filing Released Lang Actions
有価証券報告書－第127期(令和3年4月1日－令和4年3月31日)
Annual Report Classification · 100% confidence The document is identified as a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of the US 10-K. It contains the official header, fiscal period (127th term, 2021-04-01 to 2022-03-31), and detailed financial data tables, confirming it is the full annual report rather than an announcement or summary. FY 2022
2022-06-24 Japanese
四半期報告書－第127期第3四半期(令和3年10月1日－令和3年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (第３四半期報告書) for Wakamoto Pharmaceutical Co., Ltd. for the third quarter of the 127th fiscal period (ending December 31, 2021). It contains detailed financial statements (balance sheet, income statement), notes on accounting policies, and management analysis. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-02-14 Japanese
四半期報告書－第127期第2四半期(令和3年7月1日－令和3年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Wakamoto Pharmaceutical Co., Ltd. for the second quarter of the 127th fiscal period (ending September 30, 2021). It contains detailed financial statements (balance sheets, etc.), management analysis, and regulatory disclosures required under the Financial Instruments and Exchange Act of Japan. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2022
2021-11-12 Japanese
四半期報告書－第127期第1四半期(令和3年4月1日－令和3年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Wakamoto Pharmaceutical Co., Ltd., covering the first quarter of the 127th fiscal period (April 1, 2021, to June 30, 2021). It contains detailed financial statements (balance sheet, income statement) and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-08-06 Japanese
内部統制報告書－第126期(令和2年4月1日－令和3年3月31日)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act of Japan. It details the company's framework, scope, and evaluation results regarding internal controls over financial reporting. Since this is a specific regulatory filing required by law that does not fit into the other categories like 10-K or IR, it is classified as a Regulatory Filing.
2021-06-25 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act, Article 24-4-2, Paragraph 1. This is a mandatory document in Japan that accompanies the Annual Securities Report (Yukashoken Hokokusho) to confirm the accuracy of the report's contents. Since it is a regulatory filing confirming the validity of the annual report and does not contain the full financial statements or the report itself, it falls under the 'Regulatory Filings' category. FY 2021
2021-06-25 Japanese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.